List of Cancer Drugs



This list includes more than 50 cancer drug information summaries from NCI. The summaries provide consumer-friendly information about cancer drugs and drug combinations.

Summaries for individual cancer drugs cover the uses of these drugs, research results, possible side effects, approval information, and ongoing clinical trials. The list includes brand and generic names for the drugs.

Summaries for cancer drug combinations are listed by abbreviation or common name and are shown in capital letters. Each summary gives a list of the drugs that make up the combination and explains what the combination is used for. It also has links to summaries for individual drugs in the combination.


S.No Medicine Name Manufacturer Trade Name URL*
1 Abiraterone- Acetate Janssen Biotech
2 Afatnib Boehringinger Ingelheim
3 Axitinib Pfizer
4 Cabozantinib Exilixis
5 Capecitabine Genentech - Roche
6 Ceritinib Novartis
7 Cetuximab Bristol-Myers Squibb
8 Chlorambucil GlaxoSmithKline
9 Crizotinib Pfizer
10 Cyclophosphamide Bristol-Myers Squibb
11 Cytarabine Bedford Laboratories
12 Dabrafenib Novartis
13 Dasatinib Bristol - Myers Squibb
14 Doxorubicin liposome Janssen, Sun Pharma
15 Enzalutamide Astellas/Medivation
16 Eribulin Eisai
17 Erlotinib Pfizer
18 Estramustine Genentech/Roche
19 Etoposide Bristol-Myers Squibb
20 Everolimus Novartis
21 Exemestane Pfizer
22 Fulvestrant AstraZeneca
23 Gefitinib AstraZeneca
24 Ibritumomab Spectrum
25 Ibrutinib Pharmacyclic
26 Idelalisib Gilead
27 Imatinib Novartis
28 Ipilimumab Bristol-Myers Squibb
29 Ixabepilone Bristol-Myers Squibb
30 Lapatinib Novartis
31 Lenlalidomide Celgene
32 Lenvatinib Eisai
33 Lenvatinib Eisai

* If a link does not open in your Web browser, you can copy the link then paste it in the address bar of your web browser.